Characteristics of tumor infiltration by adoptively transferred and endogenous natural‐killer cells in a syngeneic rat model: Implications for the mechanism behind anti‐tumor responses
暂无分享,去创建一个
G. Fleuren | P. Kuppen | C. V. D. van de Velde | A. Eggermont | U. Nannmark | A. Eggermont | P. Basse | P. Kuppen | M. Hokland | N. G. Ensink | C. van de Velde | S. Zwaveling | M. Hagenaars | M. Hokland
[1] G. Fleuren,et al. Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti‐tumor response than systemic administration , 1998, International journal of cancer.
[2] G. Fleuren,et al. Characterization of three new membrane structures on rat NK cells which are involved in activation of the lytic machinery. , 1997, Immunobiology.
[3] K. Okumura,et al. Enhancement of lymphokine-activated killer cell activity by fibronectin. , 1997, Journal of immunotherapy.
[4] U. Nannmark,et al. Migration of IL‐2‐activated natural killer cells in vitro: influence of extracellular matrix proteins , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[5] E. Engleman,et al. Immune regulation: a critical link between NK cells and CTLs. , 1996, Immunology today.
[6] T. Whiteside,et al. Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer. , 1996, Cancer research.
[7] U. Nannmark,et al. Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (Matrigel) environment. , 1996, Natural immunity.
[8] S. Hauser,et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. , 1996, Journal of immunology.
[9] P. Musiani,et al. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[10] U. Nannmark,et al. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. , 1995, Cancer research.
[11] R. Goldfarb,et al. Non-granular proteolytic enzymes of rat interleukin-2-activated natural killer cells. III. Enhancement of A-NKP 1, 2, and 3 proteolytic activities (cleaving after Arg, Phe and Pro) in response to interleukin-2. , 1995, Natural immunity.
[12] E. Engleman,et al. Requirement for natural killer cells in the induction of cytotoxic T cells. , 1995, Journal of immunology.
[13] M. Harada,et al. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. , 1995, Immunology.
[14] G. Fleuren,et al. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin‐2‐activated natural killer cells in wag rats , 1994, International journal of cancer.
[15] R. Goldfarb,et al. Zymographic analysis of extracellular, released and cell-associated proteases of rat interleukin 2-activated natural killer (A-NK) cells. , 1994, In vivo.
[16] R. Goldfarb,et al. Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2. , 1994, In vivo.
[17] T. Whiteside,et al. Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells. , 1993, Journal of immunology.
[18] S. Steinberg,et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. , 1993, Journal of the National Cancer Institute.
[19] P. Kuppen,et al. Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. , 1993, Invasion & metastasis.
[20] R. Goldfarb,et al. Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role. , 1992, Journal of immunology.
[21] G. Fleuren,et al. Biodistribution of lymphokine‐activated killer (LAK) cells in WAG rats after hepatic‐artery or jugular‐vein infusion , 1992, International journal of cancer.
[22] S. Ratner,et al. Lymphocyte development of adherence and motility in extracellular matrix during IL-2 stimulation. , 1992, Journal of immunology.
[23] R. Goldfarb,et al. Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration. , 1992, Natural immunity.
[24] T. Whiteside,et al. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. , 1992, Journal of immunology.
[25] G. Fleuren,et al. T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody. , 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.
[26] U. Nannmark,et al. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases , 1991, The Journal of experimental medicine.
[27] U. Nannmark,et al. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. , 1991, Journal of the National Cancer Institute.
[28] R. Jain,et al. Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. , 1991, Journal of the National Cancer Institute.
[29] E. Saksela,et al. Fibronectin facilitates the migration of human natural killer cells , 1991, European journal of immunology.
[30] E. Wisse,et al. Electron microscopic observations on the accumulation of large granular lymphocytes (pit cells) and kupffer cells in the liver of rats treated with continuous infusion of interleukin‐2 , 1990, Hepatology.
[31] A. Deleo,et al. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells , 1989, The Journal of experimental medicine.
[32] R. Schwarz,et al. Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. , 1989, Cancer research.
[33] W. M. Linehan,et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. , 1987, The New England journal of medicine.
[34] R. Timpl,et al. Laminin and other basement membrane components. , 1987, Annual review of cell biology.
[35] S. Rosenberg,et al. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma. , 1985, Journal of immunology.
[36] S. Rosenberg,et al. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2. , 1985, Cancer research.
[37] J. Jeekel,et al. Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site , 1984, International journal of cancer.